Global Cancer Tumor Profiling Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Cancer Tumor Profiling Revenue
• 1.4 Market by Type
  • 1.4.1 Global Cancer Tumor Profiling Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Next-generation Sequencing (NGS)
  • 1.4.3 Polymerase Chain Reaction (PCR)
  • 1.4.4 Immunohistochemistry (IHC)
  • 1.4.5 In Situ Hybridization (ISH)
  • 1.4.6 Microarray
  • 1.4.7 Others
• 1.5 Market by Application
  • 1.5.1 Global Cancer Tumor Profiling Market Share by Application: 2020 VS 2026
  • 1.5.2 Personalized Medicine
  • 1.5.3 Diagnostics
  • 1.5.4 Biomarker Discovery
  • 1.5.5 Prognostics
  • 1.5.6 Research Applications
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Cancer Tumor Profiling Market Perspective (2015-2026)
• 2.2 Global Cancer Tumor Profiling Growth Trends by Regions
  • 2.2.1 Cancer Tumor Profiling Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Cancer Tumor Profiling Historic Market Share by Regions (2015-2020)
  • 2.2.3 Cancer Tumor Profiling Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Cancer Tumor Profiling Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Cancer Tumor Profiling Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Cancer Tumor Profiling Players by Market Size
  • 3.1.1 Global Top Cancer Tumor Profiling Players by Revenue (2015-2020)
  • 3.1.2 Global Cancer Tumor Profiling Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Cancer Tumor Profiling Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Cancer Tumor Profiling Market Concentration Ratio
  • 3.2.1 Global Cancer Tumor Profiling Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Cancer Tumor Profiling Revenue in 2019
• 3.3 Cancer Tumor Profiling Key Players Head office and Area Served
• 3.4 Key Players Cancer Tumor Profiling Product Solution and Service
• 3.5 Date of Enter into Cancer Tumor Profiling Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Cancer Tumor Profiling Historic Market Size by Type (2015-2020)
• 4.2 Global Cancer Tumor Profiling Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Cancer Tumor Profiling Market Size by Application (2015-2020)
• 5.2 Global Cancer Tumor Profiling Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Cancer Tumor Profiling Market Size (2015-2020)
• 6.2 Cancer Tumor Profiling Key Players in North America (2019-2020)
• 6.3 North America Cancer Tumor Profiling Market Size by Type (2015-2020)
• 6.4 North America Cancer Tumor Profiling Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Cancer Tumor Profiling Market Size (2015-2020)
• 7.2 Cancer Tumor Profiling Key Players in Europe (2019-2020)
• 7.3 Europe Cancer Tumor Profiling Market Size by Type (2015-2020)
• 7.4 Europe Cancer Tumor Profiling Market Size by Application (2015-2020)

8 China

• 8.1 China Cancer Tumor Profiling Market Size (2015-2020)
• 8.2 Cancer Tumor Profiling Key Players in China (2019-2020)
• 8.3 China Cancer Tumor Profiling Market Size by Type (2015-2020)
• 8.4 China Cancer Tumor Profiling Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Cancer Tumor Profiling Market Size (2015-2020)
• 9.2 Cancer Tumor Profiling Key Players in Japan (2019-2020)
• 9.3 Japan Cancer Tumor Profiling Market Size by Type (2015-2020)
• 9.4 Japan Cancer Tumor Profiling Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Cancer Tumor Profiling Market Size (2015-2020)
• 10.2 Cancer Tumor Profiling Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Cancer Tumor Profiling Market Size by Type (2015-2020)
• 10.4 Southeast Asia Cancer Tumor Profiling Market Size by Application (2015-2020)

11 India

• 11.1 India Cancer Tumor Profiling Market Size (2015-2020)
• 11.2 Cancer Tumor Profiling Key Players in India (2019-2020)
• 11.3 India Cancer Tumor Profiling Market Size by Type (2015-2020)
• 11.4 India Cancer Tumor Profiling Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Cancer Tumor Profiling Market Size (2015-2020)
• 12.2 Cancer Tumor Profiling Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Cancer Tumor Profiling Market Size by Type (2015-2020)
• 12.4 Central & South America Cancer Tumor Profiling Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Qiagen N.V.
  • 13.1.1 Qiagen N.V. Company Details
  • 13.1.2 Qiagen N.V. Business Overview
  • 13.1.3 Qiagen N.V. Cancer Tumor Profiling Introduction
  • 13.1.4 Qiagen N.V. Revenue in Cancer Tumor Profiling Business (2015-2020))
  • 13.1.5 Qiagen N.V. Recent Development
• 13.2 Roche Molecular Systems Inc.
  • 13.2.1 Roche Molecular Systems Inc. Company Details
  • 13.2.2 Roche Molecular Systems Inc. Business Overview
  • 13.2.3 Roche Molecular Systems Inc. Cancer Tumor Profiling Introduction
  • 13.2.4 Roche Molecular Systems Inc. Revenue in Cancer Tumor Profiling Business (2015-2020)
  • 13.2.5 Roche Molecular Systems Inc. Recent Development
• 13.3 Abott Molecular
  • 13.3.1 Abott Molecular Company Details
  • 13.3.2 Abott Molecular Business Overview
  • 13.3.3 Abott Molecular Cancer Tumor Profiling Introduction
  • 13.3.4 Abott Molecular Revenue in Cancer Tumor Profiling Business (2015-2020)
  • 13.3.5 Abott Molecular Recent Development
• 13.4 Illumina Inc.
  • 13.4.1 Illumina Inc. Company Details
  • 13.4.2 Illumina Inc. Business Overview
  • 13.4.3 Illumina Inc. Cancer Tumor Profiling Introduction
  • 13.4.4 Illumina Inc. Revenue in Cancer Tumor Profiling Business (2015-2020)
  • 13.4.5 Illumina Inc. Recent Development
• 13.5 NeoGenomics Laboratories
  • 13.5.1 NeoGenomics Laboratories Company Details
  • 13.5.2 NeoGenomics Laboratories Business Overview
  • 13.5.3 NeoGenomics Laboratories Cancer Tumor Profiling Introduction
  • 13.5.4 NeoGenomics Laboratories Revenue in Cancer Tumor Profiling Business (2015-2020)
  • 13.5.5 NeoGenomics Laboratories Recent Development
• 13.6 HTG Molecular Diagnostic
  • 13.6.1 HTG Molecular Diagnostic Company Details
  • 13.6.2 HTG Molecular Diagnostic Business Overview
  • 13.6.3 HTG Molecular Diagnostic Cancer Tumor Profiling Introduction
  • 13.6.4 HTG Molecular Diagnostic Revenue in Cancer Tumor Profiling Business (2015-2020)
  • 13.6.5 HTG Molecular Diagnostic Recent Development
• 13.7 Genomic Health Inc.
  • 13.7.1 Genomic Health Inc. Company Details
  • 13.7.2 Genomic Health Inc. Business Overview
  • 13.7.3 Genomic Health Inc. Cancer Tumor Profiling Introduction
  • 13.7.4 Genomic Health Inc. Revenue in Cancer Tumor Profiling Business (2015-2020)
  • 13.7.5 Genomic Health Inc. Recent Development
• 13.8 Hologic Gen-Probe
  • 13.8.1 Hologic Gen-Probe Company Details
  • 13.8.2 Hologic Gen-Probe Business Overview
  • 13.8.3 Hologic Gen-Probe Cancer Tumor Profiling Introduction
  • 13.8.4 Hologic Gen-Probe Revenue in Cancer Tumor Profiling Business (2015-2020)
  • 13.8.5 Hologic Gen-Probe Recent Development
• 13.9 BD Biosciences
  • 13.9.1 BD Biosciences Company Details
  • 13.9.2 BD Biosciences Business Overview
  • 13.9.3 BD Biosciences Cancer Tumor Profiling Introduction
  • 13.9.4 BD Biosciences Revenue in Cancer Tumor Profiling Business (2015-2020)
  • 13.9.5 BD Biosciences Recent Development
• 13.10 Siemens Healthineers
  • 13.10.1 Siemens Healthineers Company Details
  • 13.10.2 Siemens Healthineers Business Overview
  • 13.10.3 Siemens Healthineers Cancer Tumor Profiling Introduction
  • 13.10.4 Siemens Healthineers Revenue in Cancer Tumor Profiling Business (2015-2020)
  • 13.10.5 Siemens Healthineers Recent Development
• 13.11 Claris Life Sciences
  • 10.11.1 Claris Life Sciences Company Details
  • 10.11.2 Claris Life Sciences Business Overview
  • 10.11.3 Claris Life Sciences Cancer Tumor Profiling Introduction
  • 10.11.4 Claris Life Sciences Revenue in Cancer Tumor Profiling Business (2015-2020)
  • 10.11.5 Claris Life Sciences Recent Development
• 13.12 Personal Genome Diagnostics, Inc.
  • 10.12.1 Personal Genome Diagnostics, Inc. Company Details
  • 10.12.2 Personal Genome Diagnostics, Inc. Business Overview
  • 10.12.3 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Introduction
  • 10.12.4 Personal Genome Diagnostics, Inc. Revenue in Cancer Tumor Profiling Business (2015-2020)
  • 10.12.5 Personal Genome Diagnostics, Inc. Recent Development
• 13.13 Perthera, Inc.
  • 10.13.1 Perthera, Inc. Company Details
  • 10.13.2 Perthera, Inc. Business Overview
  • 10.13.3 Perthera, Inc. Cancer Tumor Profiling Introduction
  • 10.13.4 Perthera, Inc. Revenue in Cancer Tumor Profiling Business (2015-2020)
  • 10.13.5 Perthera, Inc. Recent Development
• 13.14 Foundation Medicine, Inc
  • 10.14.1 Foundation Medicine, Inc Company Details
  • 10.14.2 Foundation Medicine, Inc Business Overview
  • 10.14.3 Foundation Medicine, Inc Cancer Tumor Profiling Introduction
  • 10.14.4 Foundation Medicine, Inc Revenue in Cancer Tumor Profiling Business (2015-2020)
  • 10.14.5 Foundation Medicine, Inc Recent Development
• 13.15 V., Strand
  • 10.15.1 V., Strand Company Details
  • 10.15.2 V., Strand Business Overview
  • 10.15.3 V., Strand Cancer Tumor Profiling Introduction
  • 10.15.4 V., Strand Revenue in Cancer Tumor Profiling Business (2015-2020)
  • 10.15.5 V., Strand Recent Development
• 13.16 ApoCell
  • 10.16.1 ApoCell Company Details
  • 10.16.2 ApoCell Business Overview
  • 10.16.3 ApoCell Cancer Tumor Profiling Introduction
  • 10.16.4 ApoCell Revenue in Cancer Tumor Profiling Business (2015-2020)
  • 10.16.5 ApoCell Recent Development
• 13.17 Contextual Genomics
  • 10.17.1 Contextual Genomics Company Details
  • 10.17.2 Contextual Genomics Business Overview
  • 10.17.3 Contextual Genomics Cancer Tumor Profiling Introduction
  • 10.17.4 Contextual Genomics Revenue in Cancer Tumor Profiling Business (2015-2020)
  • 10.17.5 Contextual Genomics Recent Development
• 13.18 Agendia
  • 10.18.1 Agendia Company Details
  • 10.18.2 Agendia Business Overview
  • 10.18.3 Agendia Cancer Tumor Profiling Introduction
  • 10.18.4 Agendia Revenue in Cancer Tumor Profiling Business (2015-2020)
  • 10.18.5 Agendia Recent Development
• 13.19 GenScript
  • 10.19.1 GenScript Company Details
  • 10.19.2 GenScript Business Overview
  • 10.19.3 GenScript Cancer Tumor Profiling Introduction
  • 10.19.4 GenScript Revenue in Cancer Tumor Profiling Business (2015-2020)
  • 10.19.5 GenScript Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer